Children's cancers

This trial is looking at different types of new medicines to treat B cell non-Hodgkin lymphoma that has come back after treatment or got worse during treatment.

This trial is looking at different ways to improve treatment for Ewing’s sarcoma. It’s mainly looking at changes to chemotherapy and radiotherapy.

This trial is looking at follow up and different treatment options for people with germ cell tumours to help improve treatment results and quality of life.

This study is looking at crizotinib by itself and with temsirolimus for children and young people with cancer.

This trial is looking at the best way to treat acute lymphoblastic leukaemia (ALL) that is Philadelphia chromosome positive.

This trial is looking at naxitamab with GM-CSF to treat neuroblastoma that has continued to grow during treatment or has come back afterwards.

This study is looking at chemotherapy, radiotherapy and stem cell transplants for people with high risk neuroblastoma.

This trial is looking at sunitinib with nivolumab. It is for people whose soft tissue sarcoma or bone sarcoma has come back after treatment.

This trial is looking at pembrolizumab after chemotherapy. It is open to children from 3 years old to young adults 25 years old with classical Hodgkin lymphoma.